Compositions and methods for treatment of Parkinson's disease: a patent evaluation of WO2011/102847A1

Parkinson's Disease: Genetics and Pathogenesis

(2011) Joshua M. Shulman et al.   Annual Review of Pathology-Mechanisms of Disease

Chronic Inflammatory Disorders and Their Redox Control: From Molecular Mechanisms to Therapeutic Opportunities

(2011) Valerio Chiurchiù et al.   ANTIOXIDANTS & REDOX SIGNALING

Cell-based therapies for Parkinson’s disease

(2011) Sean C Dyson et al.   Expert Review of Neurotherapeutics

En1 and Wnt signaling in midbrain dopaminergic neuronal development

(2011) Maria TM Alves dos Santos et al.   Neural Development

ES cell-derived renewable and functional midbrain dopaminergic progenitors

(2011) S. Chung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Future of cell and gene therapies for Parkinson's disease

(2010) Ole Isacson et al.   ANNALS OF NEUROLOGY

Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons

(2010) Hyun-Jung Kim   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Wnt1-lmx1a Forms a Novel Autoregulatory Loop and Controls Midbrain Dopaminergic Differentiation Synergistically with the SHH-FoxA2 Pathway

(2009) Sangmi Chung et al.   Cell Stem Cell

Human neural progenitor and stem cells: US20080107633A1

(2009) Philippe Taupin   EXPERT OPINION ON THERAPEUTIC PATENTS

Stem Cell Therapy for Parkinson’s Disease: A Road Map for a Successful Future

(2009) Román Vidaltamayo et al.   STEM CELLS AND DEVELOPMENT

Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

(2008) Antonio Orlacchio et al.   EXPERT OPINION ON THERAPEUTIC PATENTS

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Encoding Network States by Striatal Cell Assemblies

(2008) Luis Carrillo-Reid et al.   JOURNAL OF NEUROPHYSIOLOGY